Plasminogen Interactions with Immobilized Fibrinogen

Summary

This report describes the binding of plasminogen to fibrinogen adsorbed onto polystyrene wells. Binding was determined by enzyme linked immunosorbent assay. Both glu- and lys-plasminogen bound to immobilized fibrinogen in a dose-dependent fashion. However, more lys- than glu-plasminogen bound when equal concentrations of either were added to immobilized fibrinogen. Plasminogen binding was inhibited by epsilon aminocaproic acid indicating that binding was mediated via lysine-binding regions of plasminogen. Soluble fibrinogen added in excess of immobilized fibrinogen did not compete for plasminogen binding but fibrinogen fragments produced by plasmin digestion of fibrinogen did. Treatment of immobilized fibrinogen with thrombin caused a small but significant (p <0.01) increase in plasminogen binding. These studies demonstrate that immobilized fibrinogen binds both glu- and lys-plasminogen and that binding is mediated via lysine-binding regions. These interactions may facilitate plasminogen binding to fibrinogen adsorbed on to surfaces and to cells such as platelets which bind fibrinogen.

Keywords

Plasminogen - Fibrinogen - Epsilon aminocaproic acid

• References

• 1 Salzman EW, Lindon J, McManama G, Ware JA. Role of fibrinogen in activation of platelets by artificial surfaces. Ann NY Acad Sci 1987; 516: 184-195
• 2 Lambrecht LK, Young BR, Stafford RE. et al The influence of preadsorbed canine von Willebrand factor, fibronectin and fibrinogen on ex vivo artificial surface-induced thrombosis. Thromb Res 1986; 41: 99-117
• 3 Brash JL. The fate of fibrinogen following adsorption at the blood-biomaterial interface. Ann N Y Acad Sci 1987; 516: 206-222
• 4 Bennett JS, Vilaire G, Cines DB. Identification of the fibrinogen receptor on human platelets by photoaffinity labeling. J Biol Chem 1982; 257: 8049-8054
• 5 Bennett JS, Vilaire G. Exposure of platelet fibrinogen receptors by ADP and epinephrine. J Clin Invest 1979; 64: 1393-1401
• 6 Adelman B, Rizk A, Hanners E. Plasminogen interactions with platelets in plasma. Blood 1988; 72: 1530-1535
• 7 Miles LA, Plow EF. Binding and activation of plasminogen on the platelet surface. J Biol Chem 1985; 260: 4303-4311
• 8 Miles LA, Ginsberg MH, White JG, Plow EF. Plasminogen interacts with human platelets through two distinct mechanisms. J Clin Invest 1986; 77: 2001-2009
• 9 Adelman B, Michelson AD, Loscalzo J, Greenberg J, Handin RI. Plasmin effect on platelet glycoprotein Ib - von Willebrand factor interactions. Blood 1985; 65: 032-040
• 10 Schafer AI, Adelman B. Plasmin inhibition of platelet function and of arachidonic acid metabolism. J Clin Invest 1985; 75: 456-461
• 11 Loscalzo J, Vaughan DE. Tissue plasminogen activator promotes platelet disaggregation in plasma. J Clin Invest 1987; 79: 1749-1754
• 12 Niewiarowski S, Senyi AF, Gillies P. Plasmin-induced platelet aggregation and platelet release reaction. J Clin Invest 1973; 52: 1647-1659
• 13 Lucas MA, Fretto LJ, McKee PA. The binding of human plasminogen to fibrin and fibrinogen. J Biol Chem 1982; 258: 4249-4256
• 14 Lewis MS, Carmassi F, Chung SI. Cooperative association of plasminogen with fibrinogen. Biochemistry 1984; 23: 3874-3879
• 15 Salonen E-M, Saksela O, Vartio T, Vaheri A, Nielsen LS, Zeuthen J. Plasminogen and tissue-type plasminogen activator bind to immobilized fibronectin. J Biol Chem 1985; 260: 12302-12307
• 16 Nachman RL, Leung LL. Complex formation of platelet membrane glycoproteins IIb and IIIa with fibrinogen. J Clin Invest 1982; 69: 263-269
• 17 Haverkate F, Timan G. Protective effect of calcium in the plasmin degradation of fibrinogen and fibrin fragments D. Thromb Res 1977; 10: 803-812
• 18 Robbins RC. The plasminogen-plasmin enzyme system. In: Hemostasis and Thrombosis. Coleman RW, Hirsh J, Marder VJ, Salzman EW. (eds) Lippincott; Philadelphia: 1987: 340-357
• 19 Harpel PC, Galanakis DK. Fragment x binds glu-plasminogen and catalyzes plasmin formation by t-pa. Circulation 1986; 74 (02) 002-246
• 20 Varadi A, Patthy L. Location of plasminogen-binding sites in human fibrin-ogen. Biochemistry 1983; 22: 2440-2446
• 21 Bok RA, Mangel WF. Quantitative characterization of the binding of plasminogen to intact fibrin clots, lysine-sepharose, and fibrin cleaved by plasmin. Biochemistry 1985; 24: 3279-3286
• 22 Bosma PJ, Rijken DC, Nieuwenhuizen W. Binding of tissue-type plasminogen activator to fibrinogen fragments. Eur J Biochem 1988; 172: 399-404
• 23 Beckmann R, Geiger M, Binder BR. Plasminogen activation by tissue plasminogen activator in the presence of stimulating CNBr fragment FCB-2 of fibrinogen is a two-phase reaction. J Biol Chem 1988; 15: 7176-7180
• 24 Gardlund B, Hessel B, Marguerie G, Murano G, Blomback B. Primary structure of human fibrinogen: characterization of disulfidecontaining cyanogen-bromide fragments. Eur J Biochem 1977; 77: 595-610
• 25 Silverstein RL, Leung LL, Harpel PC, Nachman RL. Complex formation of platelet thrombospondin with plasminogen modulation of activation by tissue activator. J Clin Invest 1984; 74: 1625-1633
• 26 Stricker RB, Wong D, Shiu DT, Reyes PT, Shuman MA. Activation of plasminogen by tissue plasminogen activator on normal and thrombasthenic platelets: effects on surface proteins and platelet aggregation. Blood 1986; 68: 275-280
• 27 Deguchi K, Murashima S, Shirakawa S. et al The potentiating effect of platelet on plasminogen activation by tissue plasminogen activator. Thromb Res 1985; 40: 853-861